The worldwide market for e-prescription programs is estimated at US$1.7 billion in 2023 and is projected to reach US$5.2 billion by 2030, growing at a CAGR of 17.0% from 2023 to 2030. This complete file provides an in-depth study of the market. Trends, drivers and forecasts, helping you make informed trade choices.
Expansion in the e-prescription technology market occurs through several factors. Expanding government projects and regulatory requirements aimed at reducing prescription errors and promoting patient safety are important drivers. For example, the adoption of EHRs and the push into the fitness data era in many countries have accelerated the implementation of e-prescription technologies.
The increasing incidence of electrical illnesses and corresponding trend in recovery prescriptions necessitates eco-friendly prescription control solutions, thereby further fueling market expansion. Technological advances such as the improvement of interoperable technologies facilitating seamless knowledge trading on other healthcare platforms are also contributing to the expansion of the market.
Additionally, the increasing demand for telehealth services and products, especially in the wake of the COVID-19 pandemic, has highlighted the importance of e-prescription technologies in ensuring continuity of service remotely. Another important issue is the improved focus on reducing health care costs by reducing prescription errors and improving operational efficiency through the adoption of e-prescription technologies.
These factors jointly underpin the difficult expansion trajectory of the e-prescription technology market, reflecting its integral role in modernizing healthcare delivery and improving patient outcomes.
key insights:
- Market Expansion: Understand the myriad expansion trajectory of the e-Prescription North Branch, which is predicted to reach US$3.2 billion by 2030 with a CAGR of 16.3%. The e-prescription services and products arm may also look forward to growing at a CAGR of 18.1% during the research period.
- Regional Research: Gain insight into China with a projected US market of $466.0 million in 2023 and a remarkable growth of 24.9% CAGR to reach $1.5 billion by 2030. Highlight expansion trends in Japan, Canada and other key regions. Germany, and Asia-Pacific.
Record Options:
- Complete Market Insights: Disaggregated Study of Annual Gross Sales and Market Forecasts in US$ Million from 2023 to 2030.
- In-intensity regional research: Critical insights into key markets including the US, China, Japan, Canada, Europe, Asia-Pacific, Latin America, Heart East and Africa.
- Corporate Profile: Protecting major players like Allscripts Healthcare Solutions, Inc., athenahealth, Inc., Cerner Company, and others.
- Complimentary Updates: Receive separate file updates for a week to stay up to date on fundamental market trends.
Main characteristics:
| record property | main points |
| refuse. of pages | 258 |
| forecast length | 2023 – 2030 |
| Estimated market value in 2023 (USD). | $1.7 billion |
| Estimated market value by 2030 (USD). | $5.2 billion |
| Compound Annual Extension Fee | 17.0% |
| coated area | international |
market Overview
- Influencer Marketplace Insights
- international financial replacement
- E-Prescription Program – International Key Competition Ratio Market Percentage (e) in 2024
- Aggressive Market Presence – Strong/Vibrant/Area of Interest/Insignificant (E) for Gamers International in 2024
Market Trends and Drivers
- Emerging demand for telehealth services and products expands addressable marketplace options
- Expanding government projects and regulatory requirements drive expansion in e-prescription programs
- Advancements in cloud-based platforms highlight scalability and flexibility
- Integration of synthetic logic (AI) and device finding out (ML) strengthens the industry case for predictive features
- Increasing incidence of persistent diseases drives adoption of eco-friendly prescription controls
- A better focus on patient safety and reduction in prescription errors have fueled the expansion in the e-prescription program marketplace.
- Adoption of cellular programs improves comfort for suppliers and victims
- Creation of digital prior authorization (EPA) programs speeds up the treatment solicitation process
- Emerging desire for cost relief in healthcare programs drives expansion in the e-prescription marketplace
- COVID-19 pandemic highlights use of e-prescription programs for lending resilience
- Implementation of digital health information (EHR) expands the addressable market for e-prescription programs
- Expanding funding in location data generation creates untapped options for market expansion
- Expansion of Condition Data Exchange (HIE) highlights interconnected healthcare programs
- Advances in Cybersecurity Applied Sciences Drive Adoption of Hold E-Prescription Programs
Focus on select players (General 14 featured)
- Allscripts Healthcare Answers, Inc.
- athenahealth, inc.
- cerner company
- Trade Healthcare Inc.
- PC Systems & Programs, Inc. (CPSI)
- Dr.First, Inc.
- eClinicalWorks LLC
- Epic Programs Company
- GE Healthcare
- Greenway Conditions LLC
- Henry Schein, Inc.
- meditech
- Fusion, Inc. follow the
For more information about this file visit https://www.researchandmarkets.com/r/87p0jb
About ResearchandMarkets.com
ResearchAndMarkets.com is the domain’s go-to source for global market analysis studies and market intelligence. We hand you basic knowledge on global and regional markets, leading industries, dominating corporations, fresh goods and core trends.
-
International e-Prescription Program Marketplace
Discover more from news2source
Subscribe to get the latest posts sent to your email.
